These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25275042)

  • 1. Lysophosphatidylserine stimulates chemotactic migration of colorectal cancer cells through GPR34 and PI3K/Akt pathway.
    Iida Y; H Tsuno N; Kishikawa J; Kaneko K; Murono K; Kawai K; Ikeda T; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Yatomi Y; Watanabe T
    Anticancer Res; 2014 Oct; 34(10):5465-72. PubMed ID: 25275042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position.
    Kitamura H; Makide K; Shuto A; Ikubo M; Inoue A; Suzuki K; Sato Y; Nakamura S; Otani Y; Ohwada T; Aoki J
    J Biochem; 2012 May; 151(5):511-8. PubMed ID: 22343749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein coupled receptor 34 regulates the proliferation and growth of LS174T cells through differential expression of PI3K subunits and PTEN.
    Zuo B; Wu N; Yang S; Zhong Z; Li M; Yu X; Liu Y; Yu W
    Mol Biol Rep; 2022 Apr; 49(4):2629-2639. PubMed ID: 34997428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR34 as a lysophosphatidylserine receptor.
    Makide K; Aoki J
    J Biochem; 2013 Apr; 153(4):327-9. PubMed ID: 23389307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a lysophosphatidylserine receptor on mast cells.
    Sugo T; Tachimoto H; Chikatsu T; Murakami Y; Kikukawa Y; Sato S; Kikuchi K; Nagi T; Harada M; Ogi K; Ebisawa M; Mori M
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1078-87. PubMed ID: 16460680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway.
    Li N; Bu X; Tian X; Wu P; Yang L; Huang P
    Nutr Cancer; 2012 Aug; 64(6):864-70. PubMed ID: 22860766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidylserine analogues differentially activate three LysoPS receptors.
    Uwamizu A; Inoue A; Suzuki K; Okudaira M; Shuto A; Shinjo Y; Ishiguro J; Makide K; Ikubo M; Nakamura S; Jung S; Sayama M; Otani Y; Ohwada T; Aoki J
    J Biochem; 2015 Mar; 157(3):151-60. PubMed ID: 25320102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS
    Shinjo Y; Makide K; Satoh K; Fukami F; Inoue A; Kano K; Otani Y; Ohwada T; Aoki J
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):332-338. PubMed ID: 29017923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
    Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
    Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for ligand recognition and signaling of the lysophosphatidylserine receptors GPR34 and GPR174.
    Liu G; Li X; Wang Y; Zhang X; Gong W
    PLoS Biol; 2023 Dec; 21(12):e3002387. PubMed ID: 38048360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for lysophosphatidylserine recognition by GPR34.
    Izume T; Kawahara R; Uwamizu A; Chen L; Yaginuma S; Omi J; Kawana H; Hou F; Sano FK; Tanaka T; Kobayashi K; Okamoto HH; Kise Y; Ohwada T; Aoki J; Shihoya W; Nureki O
    Nat Commun; 2024 Feb; 15(1):902. PubMed ID: 38326347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
    Yousif NG
    Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
    Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitro.
    Jin ZT; Li K; Li M; Ren ZG; Wang FS; Zhu JY; Leng XS; Yu WD
    Chin Med J (Engl); 2015 Feb; 128(4):545-9. PubMed ID: 25673461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.